Zeplatt-NT Tablet is a combination medication containing Gabapentin 400 mg and Nortriptyline 10 mg, indicated for the management of neuropathic pain and certain chronic pain conditions. Gabapentin, an anticonvulsant, modulates neuronal excitability by binding to the alpha-2-delta subunit of voltage-gated calcium channels, thereby reducing neurotransmitter release and alleviating neuropathic pain. Nortriptyline, a tricyclic antidepressant, inhibits the reuptake of norepinephrine and serotonin, enhancing pain modulation pathways and providing additional analgesic effects. This synergistic combination is particularly effective in patients who have inadequate response to monotherapy. Zeplatt-NT is prescribed for conditions such as diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain syndromes. The recommended dosage should be individualized based on patient response and tolerability, with careful titration to minimize adverse effects. Common side effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or renal impairment. Zeplatt-NT should be used under medical supervision, and abrupt discontinuation should be avoided to prevent withdrawal symptoms. This combination therapy offers a comprehensive approach to neuropathic pain management, improving patient quality of life.